A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Case study: Retrospective study of fasiglifam- Is in vitro screening study a strong tool to avoid DILI risk?
in vitroスクリーニング試験がDILIを回避できなかった事例
2020
in vitroスクリーニング試験がDILIを回避できなかった事例
Preserved Fulltext
